Cargando…

Utilization and Costs of Compounded Medications for Commercially Insured Patients, 2012-2013

BACKGROUND: Although compounding has a long-standing tradition in clinical practice, insurers and pharmacy benefit managers have instituted policies to decrease claims for compounded medications, citing questions about their safety, efficacy, high costs, and lack of FDA approval. There are no reliab...

Descripción completa

Detalles Bibliográficos
Autores principales:	McPherson, Timothy, Fontane, Patrick, Iyengar, Reethi, Henderson, Rochelle
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Academy of Managed Care Pharmacy 2016
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10398310/ https://www.ncbi.nlm.nih.gov/pubmed/27015256 http://dx.doi.org/10.18553/jmcp.2016.22.2.172

Ejemplares similares

Prescriptions by Mail Improve Access and Affordability to Medications for Medicare Part D Beneficiaries
por: Frazee, Sharon Glave, et al.
Publicado: (2014)

Medication Nonadherence Among Medicare Beneficiaries with Comorbid Chronic Conditions: Influence of Pharmacy Dispensing Channel
por: Iyengar, Reethi N., et al.
Publicado: (2016)

Association Between Dispensing Channel and Medication Adherence Among Medicare Beneficiaries Taking Medications to Treat Diabetes, High Blood Pressure, or High Blood Cholesterol
por: Iyengar, Reethi N., et al.
Publicado: (2014)

Alcohol-Attributable Medical Costs in Commercially Insured and Medicaid Populations
por: Ozluk, Pelin, et al.
Publicado: (2022)

Healthcare Utilization and Cost Burden of Porphyria in Commercially Insured Adults in the United States
por: Elsaid, Mohamed I., et al.
Publicado: (2020)

Utilization and Costs of Gender-Affirming Care in a Commercially Insured Transgender Population
por: Baker, Kellan, et al.
Publicado: (2022)

Evaluating Costs Associated With Genetic Counseling Among Commercially Insured US Patients With Cancer From 2013 to 2019
por: Roberson, Mya L., et al.
Publicado: (2022)

Sporotrichosis Cases in Commercial Insurance Data, United States, 2012–2018
por: Benedict, Kaitlin, et al.
Publicado: (2020)

Cost of Outpatient Arthroscopic Anterior Cruciate Ligament Reconstruction Among Commercially Insured Patients in the United States, 2005-2013
por: Herzog, Mackenzie M., et al.
Publicado: (2017)

Trends in utilization and costs of migraine medications, 2017–2020
por: Nguyen, Jennifer L., et al.
Publicado: (2022)

Prevalence of Nodding Syndrome — Uganda, 2012–2013
por: Iyengar, Preetha J., et al.
Publicado: (2014)

Cancer history, insurance coverage, and cost-related medication nonadherence in Medicare beneficiaries, 2013-2018
por: Li, Meng, et al.
Publicado: (2021)

Lifetime medical costs attributable to sickle cell disease among nonelderly individuals with commercial insurance
por: Johnson, Kate M., et al.
Publicado: (2022)

Costs of pediatric liver transplantation among commercially insured and Medicaid-insured patients with cholestasis in the US
por: Miloh, Tamir, et al.
Publicado: (2023)

Monthly Cost-Sharing Limits and Out-of-pocket Costs for Commercially Insured Patients in the US
por: Shafer, Paul R., et al.
Publicado: (2022)

Costs for Statutorily Insured Dental Services in Older Germans 2012–2017
por: Krasowski, Aleksander, et al.
Publicado: (2021)

Healthcare Costs of Clostridioides difficile Infection in Commercially Insured Younger Adults
por: Sahrmann, John M, et al.
Publicado: (2023)

Physics at LHC 2012
por: McPherson, R, et al.
Publicado: (2012)

A retrospective analysis to estimate the healthcare resource utilization and cost associated with treatment-resistant depression in commercially insured US patients
por: Li, Gang, et al.
Publicado: (2020)

Healthcare resource utilization and costs before and after long-acting injectable antipsychotic initiation in commercially insured young adults with schizophrenia
por: Fu, Alex Z., et al.
Publicado: (2022)

Medical Claim Cost Impact of Improved Diabetes Control for Medicare and Commercially Insured Patients with Type 2 Diabetes
por: Fitch, Kathryn, et al.
Publicado: (2013)

Utilization and Spending on Mental Health Services Among Children and Youths With Commercial Insurance
por: Kalmin, Mariah M., et al.
Publicado: (2023)

Cost of Treatment in a US Commercially Insured, HIV-1–Infected Population
por: Solem, Caitlyn T., et al.
Publicado: (2014)

Treatment Patterns and Health Care Costs in Commercially Insured Patients with Follicular Lymphoma
por: Fowler, Nathan H., et al.
Publicado: (2020)

Oral Cancer Prevalence, Mortality, and Costs in Medicaid and Commercial Insurance Claims Data
por: Tranby, Eric P., et al.
Publicado: (2022)

Out-of-Pocket Costs and Prescription Filling Behavior of Commercially Insured Individuals With Chronic Obstructive Pulmonary Disease
por: Patel, Bhavin, et al.
Publicado: (2022)

The impact of a regional patient-centered medical home initiative on cost of care among commercially insured population in the US
por: Maeng, Daniel Dukjae, et al.
Publicado: (2016)

Direct and Indirect Costs of Infectious Conjunctivitis in a Commercially Insured Population in the United States
por: Pepose, Jay S, et al.
Publicado: (2020)

Changes in Healthcare Resource Use and Costs in Commercially Insured Insomnia Patients Initiating Suvorexant
por: Kale, Hrishikesh P., et al.
Publicado: (2021)

Costs of Severe Maternal Morbidity in U.S. Commercially Insured and Medicaid Populations: An Updated Analysis
por: Black, Christopher M., et al.
Publicado: (2021)

Out-of-Pocket Costs for Colposcopy Among Commercially Insured Women From 2006 to 2019
por: Fendrick, A. Mark, et al.
Publicado: (2022)

Health Care Costs of Anal Cancer in a Commercially Insured Population in the United States
por: Wu, Chi-Fang, et al.
Publicado: (2018)

The Costs of Warfarin Underuse and Nonadherence in Patients with Atrial Fibrillation: A Commercial Insurer Perspective
por: Casciano, Julian P., et al.
Publicado: (2013)

Healthcare resource utilization, total costs, and comorbidities among patients with myotonic dystrophy using U.S. insurance claims data from 2012 to 2019
por: Howe, Sarah J., et al.
Publicado: (2022)

Enrollment in Private Medical Insurance and Utilization of Medical Services Among Children and Adolescents: Data From the 2009-2012 Korea Health Panel Surveys
por: Ryu, Dong Hee, et al.
Publicado: (2016)

Kindergarden - Enrollments 2012-2013
por: Kindergarden
Publicado: (2012)

Winter at CERN 2012/2013
por: Balle, Christoph
Publicado: (2013)

Cost trends among commercially insured and Medicare Advantage-insured patients with chronic obstructive pulmonary disease: 2006 through 2009
por: Dalal, Anand A, et al.
Publicado: (2011)

Medical Costs and Health Care Utilization Among Self-Insured Members with Carve-In Versus Carve-Out Pharmacy Benefits
por: Smith, Julia J., et al.
Publicado: (2020)

The impact of high-risk and chronic opioid use among commercially insured endometriosis patients on health care resource utilization and costs in the United States
por: Estes, Stephanie J, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_q7n47qlrsvosqkg4r89ap71va7